Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease

Oh Sang Kwon, Do Yoon Lim, Kwang An Kwon, Moon Gi Chung, Dong Kyun Park, Sun Suk Kim, Yeon Suk Kim, So Young Kwon, Yang Suh Koo, Yu Kyung Kim, Duck Joo Choi, Ju Hyun Kim, You Jin Hwang, Kwan Soo Byun, Chang Hong Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND/AIMS: Gelatinase (matrix metalloproteinase (MMP) -2 and 9) has an important role in the pathogenesis of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). In this study, we evaluated the relationship of gelatinase to chronic liver disease. METHODS: Four groups of subjects were examined; healthy control (10 cases), chronic hepatitis (18 cases), LC (15 cases), and HCC (28 cases). The plasma of each subject was obtained, and the equal quantification of plasma protein was done. The plasma activities of MMP-2 and 9 were measured by zymography. RESULTS: The activities of plasma MMP-2 in patients with LC were significantly higher than those in controls (p=0.009) and in patients with chronic hepatitis (p=0.011), but not different from those in patients with HCC. The activities of plasma MMP-9 in patients with LC were significantly higher than those in controls, but not different from those in patients with chronic hepatitis or HCC. In patients with LC (regardless of having HCC), the activities of MMP-2 correlated with total bilirubin (r=0.323, p=0.048) and Child-Pugh score (r=0.414, p=0.012). The activities of MMP-2 and 9 were higher in patients with LC (regardless of having HCC) caused by alcohol than caused by HBV (p=0.009 and 0.002 for each one). CONCLUSIONS: The plasma activity of MMP-2 may be a useful marker for the diagnosis and determination of the severity of LC. The plasma activity of MMP-9 was not useful for HCC, but may be a marker for alcoholic LC. Further study is needed to determine why the plasma activity of gelatinase was higher in patients with LC caused by alcohol than by HBV.

Original languageEnglish
Pages (from-to)222-230
Number of pages9
JournalTaehan Kan Hakhoe chi = The Korean journal of hepatology
Volume9
Issue number3
Publication statusPublished - 2003 Jan 1
Externally publishedYes

Fingerprint

Gelatinases
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Liver Cirrhosis
Liver Diseases
Chronic Disease
Hepatocellular Carcinoma
Chronic Hepatitis
Alcohols
Alcoholic Liver Cirrhosis
Bilirubin
Blood Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kwon, O. S., Lim, D. Y., Kwon, K. A., Chung, M. G., Park, D. K., Kim, S. S., ... Lee, C. H. (2003). Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease. Taehan Kan Hakhoe chi = The Korean journal of hepatology, 9(3), 222-230.

Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease. / Kwon, Oh Sang; Lim, Do Yoon; Kwon, Kwang An; Chung, Moon Gi; Park, Dong Kyun; Kim, Sun Suk; Kim, Yeon Suk; Kwon, So Young; Koo, Yang Suh; Kim, Yu Kyung; Choi, Duck Joo; Kim, Ju Hyun; Hwang, You Jin; Byun, Kwan Soo; Lee, Chang Hong.

In: Taehan Kan Hakhoe chi = The Korean journal of hepatology, Vol. 9, No. 3, 01.01.2003, p. 222-230.

Research output: Contribution to journalArticle

Kwon, OS, Lim, DY, Kwon, KA, Chung, MG, Park, DK, Kim, SS, Kim, YS, Kwon, SY, Koo, YS, Kim, YK, Choi, DJ, Kim, JH, Hwang, YJ, Byun, KS & Lee, CH 2003, 'Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease', Taehan Kan Hakhoe chi = The Korean journal of hepatology, vol. 9, no. 3, pp. 222-230.
Kwon, Oh Sang ; Lim, Do Yoon ; Kwon, Kwang An ; Chung, Moon Gi ; Park, Dong Kyun ; Kim, Sun Suk ; Kim, Yeon Suk ; Kwon, So Young ; Koo, Yang Suh ; Kim, Yu Kyung ; Choi, Duck Joo ; Kim, Ju Hyun ; Hwang, You Jin ; Byun, Kwan Soo ; Lee, Chang Hong. / Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease. In: Taehan Kan Hakhoe chi = The Korean journal of hepatology. 2003 ; Vol. 9, No. 3. pp. 222-230.
@article{08847de0188b4fcabbf3d8aa7b2b6c32,
title = "Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease",
abstract = "BACKGROUND/AIMS: Gelatinase (matrix metalloproteinase (MMP) -2 and 9) has an important role in the pathogenesis of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). In this study, we evaluated the relationship of gelatinase to chronic liver disease. METHODS: Four groups of subjects were examined; healthy control (10 cases), chronic hepatitis (18 cases), LC (15 cases), and HCC (28 cases). The plasma of each subject was obtained, and the equal quantification of plasma protein was done. The plasma activities of MMP-2 and 9 were measured by zymography. RESULTS: The activities of plasma MMP-2 in patients with LC were significantly higher than those in controls (p=0.009) and in patients with chronic hepatitis (p=0.011), but not different from those in patients with HCC. The activities of plasma MMP-9 in patients with LC were significantly higher than those in controls, but not different from those in patients with chronic hepatitis or HCC. In patients with LC (regardless of having HCC), the activities of MMP-2 correlated with total bilirubin (r=0.323, p=0.048) and Child-Pugh score (r=0.414, p=0.012). The activities of MMP-2 and 9 were higher in patients with LC (regardless of having HCC) caused by alcohol than caused by HBV (p=0.009 and 0.002 for each one). CONCLUSIONS: The plasma activity of MMP-2 may be a useful marker for the diagnosis and determination of the severity of LC. The plasma activity of MMP-9 was not useful for HCC, but may be a marker for alcoholic LC. Further study is needed to determine why the plasma activity of gelatinase was higher in patients with LC caused by alcohol than by HBV.",
author = "Kwon, {Oh Sang} and Lim, {Do Yoon} and Kwon, {Kwang An} and Chung, {Moon Gi} and Park, {Dong Kyun} and Kim, {Sun Suk} and Kim, {Yeon Suk} and Kwon, {So Young} and Koo, {Yang Suh} and Kim, {Yu Kyung} and Choi, {Duck Joo} and Kim, {Ju Hyun} and Hwang, {You Jin} and Byun, {Kwan Soo} and Lee, {Chang Hong}",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "9",
pages = "222--230",
journal = "Clinical and molecular hepatology",
issn = "2287-2728",
publisher = "Korean Association for the Study of the Liver",
number = "3",

}

TY - JOUR

T1 - Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease

AU - Kwon, Oh Sang

AU - Lim, Do Yoon

AU - Kwon, Kwang An

AU - Chung, Moon Gi

AU - Park, Dong Kyun

AU - Kim, Sun Suk

AU - Kim, Yeon Suk

AU - Kwon, So Young

AU - Koo, Yang Suh

AU - Kim, Yu Kyung

AU - Choi, Duck Joo

AU - Kim, Ju Hyun

AU - Hwang, You Jin

AU - Byun, Kwan Soo

AU - Lee, Chang Hong

PY - 2003/1/1

Y1 - 2003/1/1

N2 - BACKGROUND/AIMS: Gelatinase (matrix metalloproteinase (MMP) -2 and 9) has an important role in the pathogenesis of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). In this study, we evaluated the relationship of gelatinase to chronic liver disease. METHODS: Four groups of subjects were examined; healthy control (10 cases), chronic hepatitis (18 cases), LC (15 cases), and HCC (28 cases). The plasma of each subject was obtained, and the equal quantification of plasma protein was done. The plasma activities of MMP-2 and 9 were measured by zymography. RESULTS: The activities of plasma MMP-2 in patients with LC were significantly higher than those in controls (p=0.009) and in patients with chronic hepatitis (p=0.011), but not different from those in patients with HCC. The activities of plasma MMP-9 in patients with LC were significantly higher than those in controls, but not different from those in patients with chronic hepatitis or HCC. In patients with LC (regardless of having HCC), the activities of MMP-2 correlated with total bilirubin (r=0.323, p=0.048) and Child-Pugh score (r=0.414, p=0.012). The activities of MMP-2 and 9 were higher in patients with LC (regardless of having HCC) caused by alcohol than caused by HBV (p=0.009 and 0.002 for each one). CONCLUSIONS: The plasma activity of MMP-2 may be a useful marker for the diagnosis and determination of the severity of LC. The plasma activity of MMP-9 was not useful for HCC, but may be a marker for alcoholic LC. Further study is needed to determine why the plasma activity of gelatinase was higher in patients with LC caused by alcohol than by HBV.

AB - BACKGROUND/AIMS: Gelatinase (matrix metalloproteinase (MMP) -2 and 9) has an important role in the pathogenesis of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). In this study, we evaluated the relationship of gelatinase to chronic liver disease. METHODS: Four groups of subjects were examined; healthy control (10 cases), chronic hepatitis (18 cases), LC (15 cases), and HCC (28 cases). The plasma of each subject was obtained, and the equal quantification of plasma protein was done. The plasma activities of MMP-2 and 9 were measured by zymography. RESULTS: The activities of plasma MMP-2 in patients with LC were significantly higher than those in controls (p=0.009) and in patients with chronic hepatitis (p=0.011), but not different from those in patients with HCC. The activities of plasma MMP-9 in patients with LC were significantly higher than those in controls, but not different from those in patients with chronic hepatitis or HCC. In patients with LC (regardless of having HCC), the activities of MMP-2 correlated with total bilirubin (r=0.323, p=0.048) and Child-Pugh score (r=0.414, p=0.012). The activities of MMP-2 and 9 were higher in patients with LC (regardless of having HCC) caused by alcohol than caused by HBV (p=0.009 and 0.002 for each one). CONCLUSIONS: The plasma activity of MMP-2 may be a useful marker for the diagnosis and determination of the severity of LC. The plasma activity of MMP-9 was not useful for HCC, but may be a marker for alcoholic LC. Further study is needed to determine why the plasma activity of gelatinase was higher in patients with LC caused by alcohol than by HBV.

UR - http://www.scopus.com/inward/record.url?scp=2142801613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142801613&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 222

EP - 230

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

SN - 2287-2728

IS - 3

ER -